Interestingly, global inhibition of iNOS promoted lung repair and reverse remodeling of the pulmonary vasculature in two preclinical models of COPD, and might represent a novel treatment option, if transferrable to the human situation. This evidence concerns the gene NOS2 and chronic obstructive pulmonary disease.